254 related articles for article (PubMed ID: 9225272)
1. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
Gundlah C; Hjorth S; Auerbach SB
Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
[TBL] [Abstract][Full Text] [Related]
2. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor.
Hjorth S; Auerbach SB
Brain Res; 1999 Jul; 835(2):224-8. PubMed ID: 10415377
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
[TBL] [Abstract][Full Text] [Related]
4. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.
Hjorth S; Bengtsson HJ; Milano S
Eur J Pharmacol; 1996 Nov; 316(1):43-7. PubMed ID: 8982649
[TBL] [Abstract][Full Text] [Related]
5. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
Hjorth S; Auerbach SB
Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
[TBL] [Abstract][Full Text] [Related]
6. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
7. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
Hjorth S; Westlin D; Bengtsson HJ
Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
[TBL] [Abstract][Full Text] [Related]
8. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
9. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
Auerbach SB; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Hjorth S; Auerbach SB
Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I; Artigas F
Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
Hjorth S; Auerbach SB
Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
[TBL] [Abstract][Full Text] [Related]
15. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.
Hjorth S
J Neurochem; 1993 Feb; 60(2):776-9. PubMed ID: 8419553
[TBL] [Abstract][Full Text] [Related]
16. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
Knobelman DA; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
[TBL] [Abstract][Full Text] [Related]
17. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R; Bramante M; Samanin R
Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
[TBL] [Abstract][Full Text] [Related]
18. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
19. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
20. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
